Logo image of XAGE

LONGEVITY HEALTH HOLDINGS IN (XAGE) Stock Price, Quote, News and Overview

NASDAQ:XAGE - Nasdaq - US1429221039 - Common Stock - Currency: USD

0.165  -0.01 (-5.98%)

After market: 0.1597 -0.01 (-3.21%)

XAGE Quote, Performance and Key Statistics

LONGEVITY HEALTH HOLDINGS IN

NASDAQ:XAGE (5/2/2025, 8:00:02 PM)

After market: 0.1597 -0.01 (-3.21%)

0.165

-0.01 (-5.98%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap4.97M
Shares30.12M
Float24.08M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-29 2021-07-29


XAGE short term performance overview.The bars show the price performance of XAGE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

XAGE long term performance overview.The bars show the price performance of XAGE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of XAGE is 0.165 USD. In the past month the price increased by 21.86%.

LONGEVITY HEALTH HOLDINGS IN / XAGE Daily stock chart

XAGE Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.33 351.09B
AMGN AMGEN INC 13.55 151.20B
GILD GILEAD SCIENCES INC 13.4 129.08B
VRTX VERTEX PHARMACEUTICALS INC 1728.1 128.84B
REGN REGENERON PHARMACEUTICALS 13.67 65.39B
ARGX ARGENX SE - ADR 341.93 39.67B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 33.74B
ONC BEIGENE LTD-ADR N/A 27.57B
BNTX BIONTECH SE-ADR N/A 25.23B
NTRA NATERA INC N/A 21.18B
SMMT SUMMIT THERAPEUTICS INC N/A 20.72B
BIIB BIOGEN INC 7.81 18.10B

About XAGE

Company Profile

XAGE logo image Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.

Company Info

LONGEVITY HEALTH HOLDINGS IN

2403 Sidney Street, Suite 300

Pittsburgh PENNSYLVANIA US

Employees: 15

XAGE Company Website

Phone: 14128948248

LONGEVITY HEALTH HOLDINGS IN / XAGE FAQ

What is the stock price of LONGEVITY HEALTH HOLDINGS IN today?

The current stock price of XAGE is 0.165 USD. The price decreased by -5.98% in the last trading session.


What is the ticker symbol for LONGEVITY HEALTH HOLDINGS IN stock?

The exchange symbol of LONGEVITY HEALTH HOLDINGS IN is XAGE and it is listed on the Nasdaq exchange.


On which exchange is XAGE stock listed?

XAGE stock is listed on the Nasdaq exchange.


What is LONGEVITY HEALTH HOLDINGS IN worth?

LONGEVITY HEALTH HOLDINGS IN (XAGE) has a market capitalization of 4.97M USD. This makes XAGE a Nano Cap stock.


How many employees does LONGEVITY HEALTH HOLDINGS IN have?

LONGEVITY HEALTH HOLDINGS IN (XAGE) currently has 15 employees.


What are the support and resistance levels for LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?

LONGEVITY HEALTH HOLDINGS IN (XAGE) has a support level at 0.15. Check the full technical report for a detailed analysis of XAGE support and resistance levels.


Should I buy LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LONGEVITY HEALTH HOLDINGS IN (XAGE) stock pay dividends?

XAGE does not pay a dividend.


What is the Price/Earnings (PE) ratio of LONGEVITY HEALTH HOLDINGS IN (XAGE)?

LONGEVITY HEALTH HOLDINGS IN (XAGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).


What is the Short Interest ratio of LONGEVITY HEALTH HOLDINGS IN (XAGE) stock?

The outstanding short interest for LONGEVITY HEALTH HOLDINGS IN (XAGE) is 19.12% of its float. Check the ownership tab for more information on the XAGE short interest.


XAGE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to XAGE.


Chartmill TA Rating
Chartmill Setup Rating

XAGE Financial Highlights

Over the last trailing twelve months XAGE reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 74.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -703.41%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%97.01%
Sales Q2Q%N/A
EPS 1Y (TTM)74.02%
Revenue 1Y (TTM)-98.65%

XAGE Ownership and Analysts


Ownership
Inst Owners8.88%
Ins Owners11.63%
Short Float %19.12%
Short Ratio0.16
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A